Low-grade inflammation persisted in people with Cushing’s syndrome one year after surgery to remove disease-causing tumors that led to excess…
Articles by Steve Bryson, PhD
A federal court ruling in Texas that reversed the U.S. Food and Drug Administration’s (FDA) 23-year-old approval of mifepristone has…
The U.S. Food and Drug Administration (FDA) has granted Xeris Pharmaceuticals orphan-drug exclusivity for Recorlev (levoketoconazole), its approved…
The hormone aldosterone may contribute to high blood pressure in people with subclinical hypercortisolism — those who have high levels…
PROP1, a pituitary gland protein that regulates gene activity related to hormone production, may play a role in the development…
High levels of dietary zinc induced signs of Cushing’s syndrome in a postmenopausal mouse model, a study suggested. Weight…
11oxC19 steroids, which are part of the androgen family of male sex hormones, are the primary drivers of hyperandrogenemia in…
Single-cell analysis of non-cancerous pituitary gland tumors that cause Cushing’s disease identified a novel therapeutic target with the potential…
Researchers have identified risk factors for kidney impairment in adults with Cushing’s syndrome after they undergo surgery to remove their…
Signifor (pasireotide), a treatment for Cushing’s disease patients for whom surgery failed or is not an option, significantly reduces…